Merck | MRK - 销售收入



金融业
股票价格
USD 147.37
资产
USD 129.8B
现金及等价物
USD 6.85B
销售成本
USD 3.14B
流动资产
USD 36.68B
流动负债
USD 27.73B
债务
USD 49.12B
股息收益率
2.62
EBIT
USD 840M
EBITDA
USD -1.54B
员工
75K
EPS每股收益
USD -0.13
股本和储备
USD 41.93B
销售毛利
USD 12.09B
债务利息支出
USD 525M
利息收入
USD 35M
贷款资金
USD 51.08B
市值
USD 367.94B
净收入
USD -1.34B
营业费用
USD 15.77B
营业利润
USD 840M
普通股股本
USD 2.47B
PE价格收益
32.26
税前利润
USD -3.53B
销售收入
USD 16.6B
销售和管理费用
USD 2.89B
股票
USD 6.21B
贸易债权人
USD 3.83B
应收帐款人
USD 12.21B


销售 更改 日
AbbVie USD 16.99B 1.99B 2026-06
Abbott USD 12.59B 1.43B 2026-06
ALKERMES USD 496.01M 103.1M 2026-06
Amgen USD 10.1B 1.48B 2026-06
AstraZeneca USD 15.38B 90M 2026-06
Biogen USD 2.74B 490M 2026-06
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Coherus Biosciences USD 12.75M 1.18M 2025-12
Drreddys Laboratories INR 789.05M 86.48B 2026-03
Eli Lilly USD 22.97B 3.17B 2026-06
Gilead Sciences USD 7.8B 800M 2026-06
GlaxoSmithKline GBP 8.41B 781M 2026-06
Glaxosmithkline GBP 10.09B 1.37B 2026-03
J&J USD 25.4B 89M 2026-09
Medtronic USD 9.8B 0 2026-06
Merck USD 16.6B 310M 2026-06
Novartis USD 14.41B 1.3B 2026-06
Novartis USD 13.11B 750M 2026-03
Novo Nordisk DKK 78.49B 18.33B 2026-06
Pacira USD 192.4M 15.4M 2026-06
Perrigo USD 1.02B 51M 2026-06
Pfizer USD 15.03B 530M 2026-06
Phibro Animal Health USD 373.91M 10.02M 2025-12
Prestige Brands USD 265.71M 15.91M 2026-06
Regeneron Pharmaceuticals USD 4.29B 690M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Sanofi EUR 11.95B 710M 2026-06
Sanofi EUR 12.14B 65M 2026-03
United Therapeutics USD 783.3M 1.8M 2026-06
Zoetis USD 2.5B 200M 2026-06